Stents Technologies and Global Markets 2022-2027

Greater Incidence of Non-Communicable/Chronic Diseases Fueling Growth

The “Stents Technologies and Global Markets 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027.

The global market for stents by vascular therapeutic application is estimated to increase from $7.1 billion in 2022 to $8.7 billion by 2027, at a CAGR of 4.2% during the forecast period of 2022 through 2027.

The global market for stents by nonvascular therapeutic application is estimated to increase from $760.4 million in 2022 to $970.5 million by 2027, at a CAGR of 5.0% during the forecast period of 2022 through 2027.

The global stents market is growing at a slow to moderate rate, with different devices on different swings. The peripheral vascular stents are on an upswing and are expected to see a high growth rate worldwide. U.S., Europe, and Japan are among the largest regions in terms of stents market share. These markets are reaching a point of saturation, where opportunity is focusing not on market penetration but rather on the opportunity to replace or shift to the newest generation of stents technology.

Report Scope

  • An up-to-date review of the global markets for stents and associated medical device technologies
  • Analyses of the global market trends, with revenue sales data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Evaluation and forecast of the global stents market size, forecasted growth trends, and corresponding market share analysis by product type, therapeutic application, and geographic region
  • Identification of promising new products (stents) and technologies that are still in development and assess the probability of their successful commercialization over the next few years
  • In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of the global stents marketplace
  • Discussion of the regulatory structure for medical stents, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the medical devices industry
  • Insight into recent industry structure, the competitive landscape for major types of stents manufacturers, ongoing research activities and their clinical trials
  • Key merger and acquisition deals, product approvals/launches, agreements, collaborations, and other strategic alliances within the MedTech industry

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Chapter 4 Regulatory Structure

Chapter 5 Market Breakdown by Application

  • Overview
  • Vascular
  • Coronary
  • Peripheral Vascular
  • Nonvascular
  • Ureteral
  • Gastrointestinal
  • Biliary and Pancreatic
  • Tracheobronchial/Pulmonary
  • Global Market for Stents, by Therapeutic Application
  • Global Market for Vascular Stents, by Therapeutic Application
  • Global Market for Coronary Stents
  • Global Market for Peripheral Vascular Stents, by Therapeutic Application
  • Global Market for Nonvascular Stents, by Therapeutic Application
  • Ureteral Stents
  • Gastrointestinal Stents
  • Biliary and Pancreatic Stents
  • Tracheobronchial/Pulmonary Stents

Chapter 6 Market Breakdown by Product Type

  • Overview
  • Stent Material
  • Bare-Metal Stent (BMS)
  • Drug-Eluting Stents (DES)
  • Drugs Used in DES
  • Polymer-Based DES
  • Polymer-Free DES (PF-DES)
  • Biodegradable/Bioabsorbable Stents (BDS)
  • Technological Advantages of BDS
  • Technological Disadvantages of BDS
  • Other Stents
  • Covered Stents
  • Plastic, Hybrid Material, and Silicone Stents
  • Global Market for Stents, by Stent Type
  • Market Analysis
  • Market Revenue
  • Global Market for Vascular Stents, by Stent Type
  • Market Analysis
  • Market Revenue
  • Global Market for Coronary Stents, by Stent Type
  • Global Market for Peripheral Vascular Stents, by Stent Type
  • Global Market for Nonvascular Stents, by Stent Type
  • Market Analysis
  • Market Revenue

Chapter 7 Market Breakdown by Region

Chapter 8 Market Dynamics

  • Market Drivers
    • Favorable Global Demographics and Aging Population
    • Greater Incidence of Non-Communicable/Chronic Diseases
    • Continuous Product and Technology Developments
  • Other Drivers
  • Market Restraints
    • Alternative Technologies
    • Decline in Average Selling Prices
    • Stringent Regulatory Environment
    • Coverage and Reimbursement Issues
  • Other Restraints
  • Market Trends

Chapter 9 Competitive Landscape

  • Overview
  • Key Stent Manufacturers’ Offerings, by Application Types
  • Global Company Ranking
  • Coronary Stents
  • Peripheral Vascular Stents
  • Nonvascular Stents
  • Recent Industry Activities

Chapter 10 Company Profiles

  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Becton, Dickinson And Co.
  • Biosensors International
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • Cook Medical Llc
  • Cordis Corp.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Terumo Corp.
  • W. L. Gore & Associates, Inc.

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”